{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T02:27:57Z","timestamp":1773023277643,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008102","name":"University of Cincinnati","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["13BGIA17140069"],"award-info":[{"award-number":["13BGIA17140069"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["17GRNT33400014"],"award-info":[{"award-number":["17GRNT33400014"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Biophysics and Molecular Biology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.pbiomolbio.2020.06.001","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T11:32:20Z","timestamp":1592479940000},"page":"118-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["TRPV2 channel-based therapies in the cardiovascular field. Molecular underpinnings of clinically relevant therapies"],"prefix":"10.1016","volume":"159","author":[{"given":"Brian","family":"O\u2019Connor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheryl E.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"46","author":"Abraham","year":"2005","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.pbiomolbio.2017.05.007","article-title":"Stretch-activated TRPV2 channels: role in mediating cardiopathies","volume":"130","author":"Aguettaz","year":"2017","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ceca.2016.01.001","article-title":"Axial stretch-dependent cation entry in dystrophic cardiomyopathy: involvement of several TRPs channels","volume":"59","author":"Aguettaz","year":"2016","journal-title":"Cell Calcium"},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib4","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1111\/bph.14052","article-title":"Human podocytes express functional thermosensitive TRPV channels","volume":"174","author":"Ambrus","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2007.08.035","article-title":"Transient receptor potential V2 expressed in sensory neurons is activated by probenecid","volume":"425","author":"Bang","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib6","series-title":"Federation Proceedings. FEDERATION AMER SOC EXP BIOL 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998","first-page":"258","article-title":"Benemid (PARA-(DI-NORMAL-PROPYLSULFAMYL)-BENZOIC ACID)-AN ANTICATABOLITE-its pharmacological properties","author":"Beyer","year":"1950"},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib7","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/bioinformatics\/btm066","article-title":"NucPred - predicting nuclear localization of proteins","volume":"23","author":"Brameier","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib8","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.eururo.2007.10.016","article-title":"Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage","volume":"54","author":"Caprodossi","year":"2008","journal-title":"Eur. Urol."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib9","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/18906","article-title":"A\u00a0capsaicin-receptor homologue with a high threshold for noxious heat","volume":"398","author":"Caterina","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib10","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/jcmm.12800","article-title":"Functional TRPV2 and TRPV4 channels in human cardiac c-kit+ progenitor cells","volume":"20","author":"Che","year":"2016","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0085392","article-title":"Understanding the cellular function of TRPV2 channel through generation of specific monoclonal antibodies","volume":"8","author":"Cohen","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib12","doi-asserted-by":"crossref","first-page":"D7","DOI":"10.1093\/nar\/gkv1290","article-title":"Database resources of the national center for biotechnology information","volume":"44","author":"Coordinators","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib13","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.nmd.2004.08.002","article-title":"Characteristics of the increase in plasma brain natriuretic peptide level in left ventricular systolic dysfunction, associated with muscular dystrophy in comparison with idiopathic dilated cardiomyopathy","volume":"14","author":"Demachi","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib15","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3390\/medicina55070380","article-title":"TRP channels expression profile in human end-stage heart failure","volume":"55","author":"Dragun","year":"2019","journal-title":"Medicina"},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0177132","article-title":"TRPV2 knockout mice demonstrate an improved cardiac performance following myocardial infarction due to attenuated activity of peri-infarct macrophages","volume":"12","author":"Entin-Meer","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib17","doi-asserted-by":"crossref","first-page":"H181","DOI":"10.1152\/ajpheart.00491.2019","article-title":"Potential roles in cardiac physiology and pathology of the cation channel TRPV2 expressed in cardiac cells and cardiac macrophages: a mini-review","volume":"318","author":"Entin-Meer","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a003962","article-title":"The role of transient receptor potential cation channels in Ca2+ signaling","volume":"2","author":"Gees","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib19","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.114.014536","article-title":"Effects of xanthine oxidase inhibition in hyperuricemic heart failure patients: the xanthine oxidase inhibition for hyperuricemic heart failure patients (EXACT-HF) study","volume":"131","author":"Givertz","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib20","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/01.CIR.0000028335.31300.DA","article-title":"Results of prevention of REStenosis with tranilast and its outcomes (PRESTO) trial","volume":"106","author":"Holmes","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11130","article-title":"Structure of the full-length TRPV2 channel by cryo-EM","volume":"7","author":"Huynh","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1074248408329449","article-title":"Anandamide preserves cardiac function and geometry in an acute doxorubicin cardiotoxicity rat model","volume":"14","author":"Hydock","year":"2009","journal-title":"J.\u00a0Cardiovasc. Pharmacol. Therapeut."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib23","series-title":"Gout","first-page":"185","article-title":"Chapter 17 - drugs in the pipeline","author":"Igel","year":"2019"},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib24","article-title":"TRPV2 channel as a possible drug target for the treatment of heart failure","author":"Iwata","year":"2019","journal-title":"Lab. Invest."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib25","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1083\/jcb.200301101","article-title":"A\u00a0novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel","volume":"161","author":"Iwata","year":"2003","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib26","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/hmg\/ddn408","article-title":"Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models","volume":"18","author":"Iwata","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib27","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.bcp.2005.05.034","article-title":"Protective effects of Ca 2+ handling drugs against abnormal Ca 2+ homeostasis and cell damage in myopathic skeletal muscle cells","volume":"70","author":"Iwata","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib28","doi-asserted-by":"crossref","first-page":"14042","DOI":"10.18632\/oncotarget.24449","article-title":"Novel inhibitor candidates of TRPV2 prevent damage of dystrophic myocytes and ameliorate against dilated cardiomyopathy in a hamster model","volume":"9","author":"Iwata","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20163844","article-title":"Blockade of trpv2 is a novel therapy for cardiomyopathy in muscular dystrophy","volume":"20","author":"Iwata","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib30","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/cvr\/cvt163","article-title":"Blockade of sarcolemmal TRPV2 accumulation inhibits progression of dilated cardiomyopathy","volume":"99","author":"Iwata","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41374-019-0363-1","article-title":"Production of TRPV2-targeting functional antibody ameliorating dilated cardiomyopathy and muscular dystrophy in animal models","author":"Iwata","year":"2020","journal-title":"Lab. Invest."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms4932","article-title":"TRPV2 is critical for the maintenance of cardiac structure and function in mice","volume":"5","author":"Katanosaka","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib33","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jacc.2017.12.052","article-title":"Cardiovascular risks of probenecid versus allopurinol in older patients with gout","volume":"71","author":"Kim","year":"2018","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jaccas.2019.07.008","article-title":"Probenecid","volume":"1","author":"Klein","year":"2019","journal-title":"JACC Case Reports"},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.yjmcc.2012.04.011","article-title":"Probenecid: novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulation","volume":"53","author":"Koch","year":"2012","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib36","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/HJH.0000000000001213","article-title":"Transient receptor potential vanilloid 2 function regulates cardiac hypertrophy via stretch-induced activation","volume":"35","author":"Koch","year":"2017","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/FJC.0000000000000588","article-title":"Tranilast blunts the hypertrophic and fibrotic response to increased afterload independent of cardiomyocyte transient receptor potential vanilloid 2 channels","volume":"72","author":"Koch","year":"2019","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib38","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1016\/j.cardfail.2014.07.368","article-title":"Tranilast, orally active TRPV2 antagonist, ameliorates end-stage heart failure in mice with dilated cardiomyopathy","volume":"20","author":"Komamura","year":"2014","journal-title":"J.\u00a0Card. Fail."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib39","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s guidelines and standards committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiograph","volume":"18","author":"Lang","year":"2005","journal-title":"J.\u00a0Am. Soc. Echocardiogr."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib40","series-title":"Transient Receptor Potential Channels","first-page":"1","article-title":"Structural biology of TRP channels","author":"Li","year":"2011"},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib41","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1111\/jcmm.13665","article-title":"A\u00a0novel human S10F-Hsp20 mutation induces lethal peripartum cardiomyopathy","volume":"22","author":"Liu","year":"2018","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/cvr\/cvv021","article-title":"Dystrophic cardiomyopathy: role of TRPV2 channels in stretch-induced cell damage","volume":"106","author":"Lorin","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2169\/internalmedicine.8651-16","article-title":"A\u00a0pilot study of tranilast for cardiomyopathy of muscular dystrophy","volume":"57","author":"Matsumura","year":"2018","journal-title":"Intern. Med."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib44","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2169\/internalmedicine.49.3259","article-title":"Carvedilol can prevent cardiac events in duchenne muscular dystrophy","volume":"49","author":"Matsumura","year":"2010","journal-title":"Intern. Med."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpls.2019.00697","article-title":"Legal and regulatory issues governing cannabis and cannabis-derived products in the United States","volume":"10","author":"Mead","year":"2019","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib46","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199108293250906","article-title":"Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction","volume":"325","author":"Morgan","year":"1991","journal-title":"New Engl. J. Medcine"},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib47","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.carpath.2016.08.004","article-title":"Endoglin selectively modulates transient receptor potential channel expression in left and right heart failure","volume":"25","author":"Morine","year":"2016","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib48","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/jcsm.12273","article-title":"Systematic review and meta-analysis of cannabinoids in palliative medicine","volume":"9","author":"M\u00fccke","year":"2018","journal-title":"J.\u00a0Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib49","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/01.RES.0000097263.10220.0C","article-title":"TRPV2 is a component of osmotically sensitive cation channels in murine aortic myocytes","volume":"93","author":"Muraki","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0136901","article-title":"Transient receptor potential vanilloid 2 regulates myocardial response to exercise","volume":"10","author":"Naticchioni","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib51","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1167\/iovs.06-1355","article-title":"Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats","volume":"48","author":"Nucci","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pharmthera.2016.12.004","article-title":"Allopurinol as a therapeutic option in cardiovascular disease","volume":"172","author":"Okafor","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib53","doi-asserted-by":"crossref","first-page":"11425","DOI":"10.1523\/JNEUROSCI.1384-09.2011","article-title":"TRP vanilloid 2 knock-out mice are susceptible to perinatal lethality but display normal thermal and mechanical nociception","volume":"31","author":"Park","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib54","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ceca.2005.06.028","article-title":"TRP channels: an overview","volume":"38","author":"Pedersen","year":"2005","journal-title":"Cell Calcium"},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.48792","article-title":"Molecular mechanism of TRPV2 channel modulation by cannabidiol","volume":"8","author":"Pumroy","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib56","first-page":"1","article-title":"Probenecid improves cardiac function in patients with heart failure with reduced ejection fraction in\u00a0vivo and cardiomyocyte calcium sensitivity in\u00a0vitro","volume":"7","author":"Robbins","year":"2018","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib57","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.trsl.2013.02.003","article-title":"Targeting TRPV1 and TRPV2 for potential therapeutic interventions in cardiovascular disease","volume":"161","author":"Robbins","year":"2013","journal-title":"Transl. Res."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib58","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1152\/ajpheart.00854.2013","article-title":"Novel role of transient receptor potential vanilloid 2 in the regulation of cardiac performance","volume":"306","author":"Rubinstein","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib59","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1152\/ajpheart.1998.275.3.H961","article-title":"\u03b2-Adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy","volume":"275","author":"Shizukuda","year":"1998","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib60","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1172\/JCI111023","article-title":"Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha1 adrenergic response","volume":"72","author":"Simpson","year":"1983","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib61","first-page":"3075","article-title":"Molecular force transduction by ion channels - diversity and unifying principles","volume":"125","author":"Sukharev","year":"2012","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib62","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1067\/mhj.2002.120770","article-title":"The impact of tranilast on restenosis after coronary angioplasty: the second tranilast restenosis following angioplasty trial (TREAT-2)","volume":"143","author":"Tamai","year":"2002","journal-title":"Am. Heart J."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib63","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0002-8703(99)70025-6","article-title":"Impact of tranilast on restenosis after coronary angioplasty: tranilast restenosis following angioplasty trial (TREAT)","volume":"138","author":"Tamai","year":"1999","journal-title":"Am. Heart J."},{"key":"10.1016\/j.pbiomolbio.2020.06.001_bib64","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5599\/admet.5.2.387","article-title":"Uric acid transporter inhibitors for gout","volume":"5","author":"Tan","year":"2017","journal-title":"ADMET DMPK"}],"container-title":["Progress in Biophysics and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079610720300572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079610720300572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T21:49:00Z","timestamp":1758750540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079610720300572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":64,"alternative-id":["S0079610720300572"],"URL":"https:\/\/doi.org\/10.1016\/j.pbiomolbio.2020.06.001","relation":{},"ISSN":["0079-6107"],"issn-type":[{"value":"0079-6107","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TRPV2 channel-based therapies in the cardiovascular field. Molecular underpinnings of clinically relevant therapies","name":"articletitle","label":"Article Title"},{"value":"Progress in Biophysics and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbiomolbio.2020.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}